Hypodontia
or selective tooth agenesis is the failure to form one or more teeth during
the developmental period. 2.6%–11% of the population across the globe suffers
from this condition. The exact cause of the condition remains unknown.
Increasing number of patients suffering from hypodontia drives the growth of
the market. Additionally, increasing prevalence of different dental diseases
have increased the demand for different treatments and boosted the growth of
the market. During last decade, a number of different treatments and diagnostic
devices were introduced to improve the prognosis of the condition. Well
developed technology has supported the growth of the market in this region,
however, high cost of the treatment may slow the market growth.
The global
hypodontia market is expected to grow at a CAGR of 6.2% during the forecast
period 2017-2023.
Regional Analysis:
The Americas
dominate the global hypodontia market Size owing to a large patient population,
strong government support for research & development, and high healthcare
spending. Additionally, increasing awareness has fuelled the growth of the
market.
Europe is the
second leading global hypodontia market which is followed by Asia Pacific which
is the fastest growing market for hypodontia.
Asia Pacific
hypodontia market is majorly driven by India, and China owing to a huge patient
pool, presence of huge opportunity for the market development and continuously
developing healthcare sector.
The Middle East
and Africa contribute the least in the growth of global hypodontia market.
Among the Middle East and Africa, the Middle East dominates the market of which
the UAE, Saudi Arabia, and Kuwait are expected to be the major contributors.
However, Africa
holds the least share of the global market due to limited availability of
medical facilities and poor economic condition. However, expected growth of the
African market is high due to the presence of opportunities for the development
of the market.
Key Players:
The key players
for the global hypodontia market are Patterson
Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Pfizer
(U.S), Bayer AG (Germany), Straumann (Switzerland), Danaher Corporation
(Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S), Biolase Inc (U.S), KERR Corporation (U.S), GC
orthodontics (Germany),, and American Orthodontics (U.S).
Browse Complete Premium
Research Report at https://www.marketresearchfuture.com/reports/hypodontia-market-5044
Segmentation:
The global
hypodontia market is segmented on the basis of causes, treatment, and end
users.
On the basis of
the causes, the market is segmented hormonal defects, infection, genetics,
environmental, and others. Hormonal defects is further segmented into
idiopathic hypoparathyroidism and pseudohypoparathyroidism. Infection is
further segmented into rubella, candida, and others. Genetics is sub segmented
into MSX1 and PAX9.
On the basis of
the treatment, the market is segmented into paediatric dentistry, restorative
dentistry, orthodontics, oral surgery, and others.
On the basis of
the end users, the market is segmented into hospital & clinics, dental
centers, and others.
About Market Research
Future: MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by products,
services, technologies, applications, end users, and market players for global,
regional, and country level market segments, enable our clients to see more,
know more, and do more, which help to answer all their most important
questions.
Comments
Post a Comment